Jane Kenny

Dr. Jane Kenny is currently Associate Director/Principal Scientist at Genentech. Jane received her Ph.D. from the University of Liverpool, UK, under Prof. B. Kevin Park and has over 15 years of drug discovery and development experience. She leads in vitro ADME at Genentech which is responsible for clearance, binding, and DDI evaluation spanning early discovery to late development. This group also has a focus on computational ADME. Her research interests include DDI, IVIVE, PBPK, and predictive ADMET. She is active in the DMPK scientific community and has published over 40 peer-reviewed articles, reviews, and book chapters.